Adamas Pharmaceuticals (ADMS) Stock Analysis

What Adamas Pharmaceuticals does

Adamas Pharmaceuticals, Inc. is focused on the research, development, and commercialization of therapeutic solutions for individuals in the United States suffering from chronic neurological conditions. The company's marketed products include GOCOVRI, an extended-release capsule designed to treat dyskinesia in Parkinson's disease patients who are undergoing levodopa-based therapy, with or without other dopaminergic medications. Additionally, they provide Namzaric capsules, a combination of extended-release memantine hydrochloride and donepezil hydrochloride, used for managing moderate to severe Alzheimer's-type dementia. In its development pipeline, Adamas is progressing ADS-5102, which is currently undergoing Phase III clinical trials to address walking difficulties in patients with multiple sclerosis, among other potential applications. The firm has also completed two Phase I studies for ADS-4101, a candidate treatment for partial onset seizures in epilepsy patients. Founded in 2000, the company initially operated as NeuroMolecular Pharmaceuticals, Inc. before changing its name to Adamas Pharmaceuticals, Inc. in July 2007. Its corporate headquarters are located in Emeryville, California.

Key metrics

ETFs linked to ADMS

Broad-market and Healthcare sector ETFs an investor holding Adamas Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ADMS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Adamas Pharmaceuticals?

Adamas Pharmaceuticals trades under the ticker ADMS on NASDAQ.

Which exchange is ADMS listed on?

ADMS is listed on NASDAQ.

What sector does Adamas Pharmaceuticals operate in?

Adamas Pharmaceuticals is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze ADMS in a portfolio?

PortView shows ADMS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.